D. E. Shaw & Co., Inc. Co Diagnostics, Inc. Transaction History

D. E. Shaw & Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.5 $85 - $127	-85 Reduced 0.18%	46,305 $61,000
Q3 2023 Nov 14, 2023	SELL	$1.03 - $1.85 $6,549 - $11,764	-6,359 Reduced 12.06%	46,390 $49,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.64 $2,709 - $4,272	-2,605 Reduced 4.71%	52,749 $58,000
Q1 2023 May 15, 2023	SELL	$1.39 - $3.24 $12,489 - $29,111	-8,985 Reduced 13.97%	55,354 $81,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $136,274 - $216,159	-58,739 Reduced 47.73%	64,339 $162,000
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $234,573 - $572,948	81,733 Added 197.69%	123,078 $395,000
Q2 2022 Aug 15, 2022	BUY	$3.76 - $6.29 $14,190 - $23,738	3,774 Added 10.04%	41,345 $232,000
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $89,136 - $170,298	17,721 Added 89.27%	37,571 $232,000
Q4 2021 Feb 14, 2022	BUY	$8.12 - $10.37 $161,181 - $205,844	19,850 New	19,850 $177,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $271,097 - $412,445	-36,243 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $259,499 - $346,483	36,243 New	36,243 $299,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.